Lucy Therapeutics

Lucy Therapeutics is a Boston-based biotechnology company with a unified mitochondrial platform, developing small molecule therapies for neurological disorders and unique peripheral mitochondrial biomarkers. LucyTx's platform identifies targets that can improve central energy dysfunction in these diseases and selectively addresses their complex organ symptoms in both diseased and healthy cells. LucyTx interrogates complex biology with well-defined molecules to answer critical questions about key pathways in disease modification.